Bethany Sensenig
Chief Financial Officer, 9 METERS BIOPHARMA, INC.
Companies
- Alpha Cognition Inc.Board member Apr 17, 2026 to now1
- KalVista Pharmaceuticals, Inc.Board member Oct 2, 2025 to now2
- SUPERNUS PHARMACEUTICALS, INC.Board member Aug 21, 2023 to now3
- 9 METERS BIOPHARMA, INC.Chief financial officer Jan 18, 2022 to Apr 21, 20234
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Alpha Cognition Inc. ACOG5,489 shares5$45.0K at $8.19Apr 16, 2026
- SUPERNUS PHARMACEUTICALS, INC. SUPN0 shares6Feb 19, 2026
- 9 METERS BIOPHARMA, INC.41,077 shares7Apr 21, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 16, 2026Granted 5,489 shares of Alpha Cognition Inc.5
- Feb 19, 2026Sold 3,258 shares at $51.27 of SUPERNUS PHARMACEUTICALS, INC.6
- Feb 19, 2026Sold 1,217 shares at $50.31 of SUPERNUS PHARMACEUTICALS, INC.6
- Feb 19, 2026Exercised options 4,475 shares of SUPERNUS PHARMACEUTICALS, INC.6
- Aug 14, 2025Sold 5,369 shares at $42.25 of SUPERNUS PHARMACEUTICALS, INC.8
- Feb 22, 2025Granted 5,369 shares of SUPERNUS PHARMACEUTICALS, INC.9
- Apr 21, 2023Sold 9,100 shares at $1.21 of 9 METERS BIOPHARMA, INC.7
- Mar 27, 2023Granted 50,177 shares of 9 METERS BIOPHARMA, INC.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAlpha Cognition Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Aug 18, 2025
- 9SEC EDGARForm 4 filed Feb 24, 2025
- 10SEC EDGARForm 4 filed Mar 29, 2023